A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China

Enrolling by invitationOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

August 1, 2030

Study Completion Date

December 30, 2032

Conditions
Myotonic Dystrophy 1
Interventions
DIAGNOSTIC_TEST

MRI scan

Brain MRI scan to evaluate the integrity of the nervous system; lower limb muscle MRI scan to evaluate fat infiltration in skeletal muscles of the lower limb

DIAGNOSTIC_TEST

Electrocardiography

Standard 12-lead electrocardiography or Holter monitoring performed to assess cardiac conduction abnormalities and arrhythmias in patients with DM1.

DIAGNOSTIC_TEST

Pulmonary function test

Comprehensive pulmonary function testing including spirometry to assess respiratory muscle weakness and restrictive lung disease in DM1 patients.

Trial Locations (22)

200040

Huashan Hospital, Shanghai

Unknown

Chinese People's Liberation Army General Hospital, Beijing

Peking University First Hospital, Beijing

First Affiliated Hospital of Chongqing Medical University, Chongqing

Fujian Medical University Union Hospital, Fuzhou

Southern Hospital of Southern Medical University, Guangzhou

The Third Hospital of Hebei Medical University, Shijiazhuang

Wuhan University People's Hospital, Wuhan

Zhongda Hospital Southeast University, Nanjing

The First Affiliated Hospital of Soochow University, Suzhou

The First People's Hospital of Yancheng, Yancheng

The First Affiliated Hospital of Nanchang University), Nanchang

The First Bethune Hospital of Jilin University, Changchun

Chifeng Municipal Hospital, Chifeng

Qilu Hospital of Shandong University, Jinan

Children's Hospital of Fudan University, Shanghai

First Hospital of Shanxi Medical University, Taiyuan

Xi'an Gaoxin Hospital, Xi’an

Xi'an People's Hospital, Xi’an

Sichuan Provincial People's Hospital, Chengdu

The General Hospital of Western Theater Command, Chengdu

Yunnan Provincial People's Hospital, Kunming

All Listed Sponsors
lead

Huashan Hospital

OTHER